Role of FK506 binding protein 12 in morphine-induced μ-opioid receptor internalization and desensitization

Neuroscience Letters

Volumn 566, Issue , 2014, Pages 231-235

  Yan, Ying Hui ^a   Wang, Yan ^a,c   Zhao, Lan Xue ^a   Jiang, Shan ^a   Loh, Horace H ^b   Law, Ping Yee ^b   Chen, Hong Zhuan ^a   Qiu, Yu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Opioid receptor; Desensitization; FK506 binding protein 12; Internalization; Morphine

Indexed keywords

ADENYLATE CYCLASE; CIS TRANS ISOMERASE; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; PROTEIN KINASE C; SMALL INTERFERING RNA; TACROLIMUS; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; INTERNALIZATION; MORPHINE TOLERANCE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR INTERNALIZATION;

DESENSITIZATION; FK506 BINDING PROTEIN 12; INTERNALIZATION; MORPHINE; Μ-OPIOID RECEPTOR;

ADENYLATE CYCLASE; HEK293 CELLS; HUMANS; MORPHINE; MUTATION; PHOSPHORYLATION; RECEPTORS, OPIOID, MU; RNA, SMALL INTERFERING; TACROLIMUS; TACROLIMUS BINDING PROTEIN 1A;

EID: 84897885475     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.02.059     Document Type: Article

References (33)

1. Kieffer B.L. Opioids: first lessons from knockout mice. Trends Pharmacol. Sci. 1999, 20:19-26.
2. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 2001, 53:1-24.
3. Bohn L.M., Lefkowitz R.J., Caron M.G. Differential mechanisms of morphine antinociceptive tolerance revealed in beta arrestin-2 knock-out mice. J. Neurosci. 2002, 22:10494-10500.
4. Zheng H., Loh H.H., Law P.-Y. Arrestin-dependent {μ}-opioid receptor-activated extracellular signal-regulated kinases (ERKs) translocate to nucleus in contrast to G protein-dependent ERK activation. Mol. Pharmacol. 2008, 73:178-190.
5. Smith F.L., Javed R., Elzey M.J., Welch S.P., Selley D., Sim-Selley L., Dewey W.L. Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors. Brain Res. 2002, 958:28-35.
6. Bailey C.P., Llorente J., Gabra B.H., Smith F.L., Dewey W.L., Kelly E., Henderson G. Role of protein kinase C and μ-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. Eur. J. Neurosci. 2009, 29:307-318.
7. Qiu Y., Law P.Y., Loh H.H. Mu-opioid receptor desensitization: role of receptor phosphorylation, internalization, and representation. J. Biol. Chem. 2003, 278:36733-36739.
8. Koch T., Widera A., Bartzsch K., Schulz S., Brandenburg L.O., Wundrack N., Beyer A., Grecksch G., Hollt V. Receptor endocytosis counteracts the development of opioid tolerance. Mol. Pharmacol. 2005, 67:280-287.
9. Whistler J.L., Chuang H.H., Chu P., Jan L.Y., von Zastrow M. Functional dissociation of μ opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 1999, 23:737-746.
10. He L., Fong J., von Zastrow M., Whistler J.L. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 2002, 108:271-282.
11. Liang Y.J., Wu D.F., Yang L.Q., Hollt V., Koch T. Interaction of the μ-opioid receptor with synaptophysin influences receptor trafficking and signaling. Mol. Pharmacol. 2007, 71:123-131.
12. Koch T., Brandenburg L.O., Schulz S., Liang Y., Klein J., Hollt V. ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced μ-opioid receptor endocytosis. J. Biol. Chem. 2003, 278:9979-9985.
13. Wu D.F., Koch T., Liang Y.J., Stumm R., Schulz S., Schroder H., Hollt V. Membrane glycoprotein M6a interacts with the μ-opioid receptor and facilitates receptor endocytosis and recycling. J. Biol. Chem. 2007, 282:22239-22247.
14. Ge X., Qiu Y., Loh H.H., Law P.Y. GRIN1 regulates μ-opioid receptor activities by tethering the receptor and G protein in the lipid raft. J. Biol. Chem. 2009, 284:36521-36534.
15. Qiu Y., Zhao W., Wang Y., Xu J.R., Huie E., Jiang S., Yan Y.H., Loh H.H., Chen H.Z., Law P.Y. FK506-binding protein 12 modulates μ-opioid receptor phosphorylation and protein kinase C{varepsilon}-dependent signaling by its direct interaction with the receptor. Mol. Pharmacol. 2014, 85:37-49.
16. Park S.T., Aldape R.A., Futer O., DeCenzo M.T., Livingston D.J. PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism. J. Biol. Chem. 1992, 267:3316-3324.
17. Steiner J.P., Dawson T.M., Fotuhi M., Glatt C.E., Snowman A.M., Cohen N., Snyder S.H. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 1992, 358:584-587.
18. Guzman-Lenis M.S., Vallejo C., Navarro X., Casas C. Analysis of FK506-mediated protection in an organotypic model of spinal cord damage: heat shock protein 70 levels are modulated in microglial cells. Neuroscience 2008, 155:104-113.
19. Hoeffer C.A., Tang W., Wong H., Santillan A., Patterson R.J., Martinez L.A., Tejada-Simon M.V., Paylor R., Hamilton S.L., Klann E. Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. Neuron 2008, 60:832-845.
20. Gerard M., Debyser Z., Desender L., Baert J., Brandt I., Baekelandt V., Engelborghs Y. FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T. J. Neurochem. 2008, 106:121-133.
21. Kim C.M., Dion S.B., Onorato J.J., Benovic J.L. Expression and characterization of two beta-adrenergic receptor kinase isoforms using the baculovirus expression system. Receptor 1993, 3:39-55.
22. Giordano A., Romano S., Mallardo M., D'Angelillo A., Cali G., Corcione N., Ferraro P., Romano M.F. FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation. Cardiovasc. Res. 2008, 79:519-526.
23. Gothel S.F., Schmid R., Wipat A., Carter N.M., Emmerson P.T., Harwood C.R., Marahiel M.A. An internal FK506-binding domain is the catalytic core of the prolyl isomerase activity associated with the Bacillus subtilis trigger factor. Eur. J. Biochem. 1997, 244:59-65.
24. Palmer T.M., Benovic J.L., Stiles G.L. Agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor. Evidence for a G-protein-coupled receptor kinase-mediated mechanism. J. Biol. Chem. 1995, 270:29607-29613.
25. Claude-Geppert P.A., Liu J., Solberg J., Erickson-Herbrandson L.J., Loh H.H., Law P.Y. Antagonist efficacy in MORS196L mutant is affected by the interaction between transmembrane domains of the opioid receptor. J. Pharmacol. Exp. Ther. 2005, 313:216-226.
26. Tradler T., Stoller G., Rucknagel K.P., Schierhorn A., Rahfeld J.U., Fischer G. Comparative mutational analysis of peptidyl prolyl cis/trans isomerases: active sites of Escherichia coli trigger factor and human FKBP12. FEBS Lett. 1997, 407:184-190.
27. Pak Y., O'Dowd B.F., George S.R. Agonist-induced desensitization of the μ opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J. Biol. Chem. 1997, 272:24961-24965.
28. Law P.Y., Erickson L.J., El-Kouhen R., Dicker L., Solberg J., Wang W., Miller E., Burd A.L., Loh H.H. Receptor density and recycling affect the rate of agonist-induced desensitization of μ-opioid receptor. Mol. Pharmacol. 2000, 58:388-398.
29. Chu J., Zheng H., Loh H.H., Law P.Y. Morphine-induced μ-opioid receptor rapid desensitization is independent of receptor phosphorylation and beta-arrestins. Cell Signalling 2008, 20:1616-1624.
30. Chu J., Zheng H., Zhang Y., Loh H.H., Law P.Y. Agonist-dependent μ-opioid receptor signaling can lead to heterologous desensitization. Cell Signalling 2010, 22:684-696.
31. Koch T., Hollt V. Role of receptor internalization in opioid tolerance and dependence. Pharmacol. Ther. 2008, 117:199-206.
32. Homayoun H., Khavandgar S., Mehr S.E., Namiranian K., Dehpour A.R. The effects of FK506 on the development and expression of morphine tolerance and dependence in mice. Behav. Pharmacol. 2003, 14:121-127.
33. McClung C.A., Nestler E.J., Zachariou V. Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J. Neurosci. 2005, 25:6005-6015.